 |
All India Launch with 400 field personnel (July, 2002). |
|
Fastest to cross ORG-IMS reflections of 100 Cr., 200 Cr. and now even 1000 Cr. mark. |
|
Launch of specialty focused divisions for effective penetration in multiple specialties and market segments. |
| |
 |
Gromaxx: 2005 – Gastroenterology & Respiratory |
|
Oncocare: 2008 – Anticancer |
|
Odenea: 2010 – Pain Management |
|
Generia & Institutions: 2012 – To tap vast potential of generics and hospitals, institutes |
|
Lifestyle: – Cardiac and Diabetes Management |
|
|
Building leader brands: (Source: AIOCD-AWACS) |
| |
|
Augpen |
|
Maxtra |
|
Eslo |
|
Feronia |
|
Bevon |
|
Merotec |
|
Zostum |
|
Coralium D3 |
|
Myotop |
|
Rabifast |
|
Soventus |
|
Vitanova |
|
Zuvirab |
|
Cortimax |
|
|
Successful entry into exciting field of biotechnology – Enoxarin, Eporise, Peglast. |
|
Forayed into Preventive Medicine segment with launch of Vaccines with Vac T, Zuvirab & Zuvicella. |
|
Partnership with MNCs for exciting cutting edge products |
| |
|
Have been marketing Gutclear containing Lactitol from DuPont with their technical support |
|
Launched DuPont probiotic Restore II under Zuventus own brand name Floristore |
|
|
Launching of First time in India molecules with unique mode of action: Troxip (Troxipide), Lafaxid (Lafutidine), Seretra (Seratrodast), Efnocar (Efonidipine), Fibricor (Ibutilide), Tosiban (Atosiban),Evanew Gloves. |
|
Setting up our own Manufacturing unit for Oral and Injectable Cephalosporins at Jammu in June 11, Oral Solid Dosage Form unit at Sikkim with dedicated Beta lactam area in March 2017 and a dedicated Liquid Manufacturing unit at Bengaluru in November 2017 |
|
Our own Formulation R&D starting October’12. |